Belite Bio Adr Stock Return On Asset
Belite Bio ADR fundamentals help investors to digest information that contributes to Belite Bio's financial success or failures. It also enables traders to predict the movement of Belite Stock. The fundamental analysis module provides a way to measure Belite Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Belite Bio stock.
Belite |
Belite Bio ADR Company Return On Asset Analysis
Belite Bio's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Belite Bio Return On Asset | -0.2 |
Most of Belite Bio's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Belite Bio ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Belite Bio ADR has a Return On Asset of -0.2026. This is 97.68% lower than that of the Biotechnology sector and 99.14% lower than that of the Health Care industry. The return on asset for all United States stocks is 44.71% higher than that of the company.
Belite Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Belite Bio's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Belite Bio could also be used in its relative valuation, which is a method of valuing Belite Bio by comparing valuation metrics of similar companies.Belite Bio is currently under evaluation in return on asset category among its peers.
Belite Fundamentals
| Return On Equity | -0.31 | ||||
| Return On Asset | -0.2 | ||||
| Current Valuation | 2.04 B | ||||
| Shares Outstanding | 32.28 M | ||||
| Shares Owned By Insiders | 55.04 % | ||||
| Shares Owned By Institutions | 1.10 % | ||||
| Number Of Shares Shorted | 69.35 K | ||||
| Price To Book | 14.99 X | ||||
| EBITDA | (39.83 M) | ||||
| Net Income | (36.14 M) | ||||
| Cash And Equivalents | 48.7 M | ||||
| Cash Per Share | 1.96 X | ||||
| Total Debt | 537 K | ||||
| Current Ratio | 35.01 X | ||||
| Book Value Per Share | 4.58 X | ||||
| Cash Flow From Operations | (29.23 M) | ||||
| Short Ratio | 2.47 X | ||||
| Earnings Per Share | (1.18) X | ||||
| Target Price | 84.75 | ||||
| Number Of Employees | 25 | ||||
| Beta | -1.54 | ||||
| Market Capitalization | 2.19 B | ||||
| Total Asset | 152.13 M | ||||
| Retained Earnings | (107.65 M) | ||||
| Working Capital | 141.02 M | ||||
| Net Asset | 152.13 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Tools for Belite Stock
When running Belite Bio's price analysis, check to measure Belite Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Belite Bio is operating at the current time. Most of Belite Bio's value examination focuses on studying past and present price action to predict the probability of Belite Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Belite Bio's price. Additionally, you may evaluate how the addition of Belite Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |